From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly

[1]  R. Webster,et al.  The Antibody Response , 2008 .

[2]  M. Irwin.  Human psychoneuroimmunology: 20 Years of discovery , 2008, Brain, Behavior, and Immunity.

[3]  P. Friend,et al.  Homeostatic Repopulation by CD28−CD8+ T Cells in Alemtuzumab‐Depleted Kidney Transplant Recipients Treated With Reduced Immunosuppression , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  D. Carroll,et al.  Cytomegalovirus is associated with depression and anxiety in older adults , 2008, Brain, Behavior, and Immunity.

[5]  F. Schmidt.  Meta-Analysis , 2008 .

[6]  C. Patterson,et al.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging , 2007, Neurobiology of Aging.

[7]  I. Scott,et al.  Analysing low-risk patient populations allows better discrimination between high-performing and low-performing hospitals: a case study using inhospital mortality from acute myocardial infarction , 2007, Quality and Safety in Health Care.

[8]  G. Hansson,et al.  Innate immunity, macrophage activation, and atherosclerosis , 2007, Immunological reviews.

[9]  C. Brayne,et al.  Prevalence and symptomatology of depression in older people living in institutions in England and Wales. , 2007, Age and ageing.

[10]  M. Irwin,et al.  Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes , 2007, Biological Psychiatry.

[11]  G. Pawelec,et al.  No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study , 2007, Experimental Gerontology.

[12]  J. Myśliwska,et al.  Long-term prognosis after coronary bypass surgery depends on interleukin 6 polymorphism and past acute infections. , 2007, International journal of cardiology.

[13]  V. Salomaa,et al.  Endotoxemia, Immune Response to Periodontal Pathogens, and Systemic Inflammation Associate With Incident Cardiovascular Disease Events , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Myśliwska,et al.  NK cell compartment in patients with coronary heart disease , 2007, Immunity & Ageing.

[15]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[16]  Roger I Glass,et al.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[17]  R. Pazoki,et al.  The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study , 2006, Cardiovascular diabetology.

[18]  W. Flanders,et al.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Myśliwska,et al.  Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. , 2006, European cytokine network.

[20]  G. Pawelec,et al.  The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning , 2006, Mechanisms of Ageing and Development.

[21]  J. Myśliwska,et al.  CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. , 2006, Clinical immunology.

[22]  G. Pawelec,et al.  Human cytomegalovirus infection and T cell immunosenescence: A mini review , 2006, Mechanisms of Ageing and Development.

[23]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[24]  G. Pawelec,et al.  Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly1 , 2006, The Journal of Immunology.

[25]  C. Beaulieu,et al.  Diffusion tensor spectroscopy (DTS) of human brain , 2006, Magnetic resonance in medicine.

[26]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[27]  K. Hirokawa,et al.  A Need to Study the Immune Status of Frail Older Adults , 2006, Immunity & Ageing.

[28]  L. Turka,et al.  Homeostatic T cell proliferation as a barrier to T cell tolerance , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[29]  S. Castle,et al.  Comorbidity Is a Better Predictor of Impaired Immunity than Chronological Age in Older Adults , 2005, Journal of the American Geriatrics Society.

[30]  G. Pawelec,et al.  Human immunosenescence: is it infectious? , 2005, Immunological reviews.

[31]  G. Pawelec,et al.  An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[32]  M. Mimura,et al.  High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia , 2005, Journal of the American Geriatrics Society.

[33]  R. Würzner,et al.  Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+ T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons , 2005, Journal of Virology.

[34]  R. Carney,et al.  Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. , 2005, The American journal of cardiology.

[35]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[36]  J. Myśliwska,et al.  Immunomodulating effect of influenza vaccination in the elderly differing in health status , 2004, Experimental Gerontology.

[37]  J. Maciejewski,et al.  Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form , 2004, British journal of haematology.

[38]  G. Pawelec,et al.  Dysfunctional CMV-specific CD8+ T cells accumulate in the elderly , 2004, Experimental Gerontology.

[39]  B. Godlewska,et al.  Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients , 2004, Brain, Behavior, and Immunity.

[40]  Imran Awan,et al.  Influenza and cardiovascular disease: is there a causal relationship? , 2004, Texas Heart Institute journal.

[41]  T. Wreghitt,et al.  Cytomegalovirus infection in immunocompetent patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[43]  C. Franceschi,et al.  Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence , 2003, Experimental Gerontology.

[44]  D. Voehringer,et al.  Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1) , 2003, Experimental Gerontology.

[45]  L. Ferrucci,et al.  Serum IL-1beta levels in health and disease: a population-based study. 'The InCHIANTI study'. , 2003, Cytokine.

[46]  M. Schroll,et al.  Predicting death from tumour necrosis factor‐alpha and interleukin‐6 in 80‐year‐old people , 2003, Clinical and experimental immunology.

[47]  C. Franceschi,et al.  Centenarians as a model for healthy aging. , 2003, Biochemical Society transactions.

[48]  S. E. Gartside,et al.  Flattening the Glucocorticoid Rhythm causes Changes in Hippocampal Expression of Messenger RNAs Coding Structural and Functional Proteins: Implications for Aging and Depression , 2003, Neuropsychopharmacology.

[49]  S. Humphries,et al.  In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[50]  G. Pawelec,et al.  Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. , 2002, Trends in immunology.

[51]  Trang Vu,et al.  A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. , 2002, Vaccine.

[52]  M. Schwarz,et al.  T-helper-1 and T-helper-2 Responses in Psychiatric Disorders , 2001, Brain, Behavior, and Immunity.

[53]  E. Hawe,et al.  The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. , 2001, European heart journal.

[54]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[55]  N. Letvin,et al.  CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. , 2001, Current opinion in immunology.

[56]  P. Dicorleto,et al.  Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity. , 2001, Cardiovascular research.

[57]  G. Pawelec,et al.  The SENIEUR protocol after 16 years , 2001, Mechanisms of Ageing and Development.

[58]  M. D. de Baets,et al.  Inflammation, depressive symptomtology, and coronary artery disease. , 2000, Psychosomatic medicine.

[59]  C. Franceschi,et al.  Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. , 2000, Vaccine.

[60]  R. Baldwin.  Poor prognosis of depression in elderly people: causes and actions , 2000, Annals of medicine.

[61]  M. Krstic-Demonacos,et al.  Glucocorticoid receptors in ageing rats , 1999, Experimental Gerontology.

[62]  D. Munn,et al.  Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? , 1999, Immunology today.

[63]  C. Irwin,et al.  Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. , 1999, International immunology.

[64]  J. Myśliwska,et al.  The upregulation of TNFα production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life , 1999, Mechanisms of Ageing and Development.

[65]  B. McEwen,et al.  Increased Cortisol Levels and Impaired Cognition in Human Aging: Implication for Depression and Dementia in Later Life , 1999, Reviews in the neurosciences.

[66]  I. Heuser,et al.  Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. , 1998, Stress.

[67]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[68]  D. Carr,et al.  Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. , 1998, Journal of immunology.

[69]  E. Bosmans,et al.  The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. , 1998, Journal of affective disorders.

[70]  P. Ridker,et al.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. , 1998, Circulation.

[71]  N. Cox,et al.  [Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. , 1998, Voprosy virusologii.

[72]  G. Pawelec,et al.  Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? , 1997, Immunology today.

[73]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[74]  R. Schmidt,et al.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. , 1997, The American journal of pathology.

[75]  B. Johansson,et al.  Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[76]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[77]  M P Lawton,et al.  Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population , 1995, Journal of the American Geriatrics Society.

[78]  D. Ferrari,et al.  Activation of microglial cells by beta-amyloid protein and interferon-gamma. , 1995, Nature.

[79]  M. Leon,et al.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.

[80]  S. Gravenstein,et al.  Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.

[81]  B. Pozzetto,et al.  Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data. , 1993, Gerontology.

[82]  D. Mabey,et al.  Chlamydia pneumoniae and atherosclerosis , 1993, The Lancet.

[83]  W. Beyer,et al.  Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. , 1993, Vaccine.

[84]  M. Ponec,et al.  Glucocorticoid receptors. , 1993, Current problems in dermatology.

[85]  C. Franceschi,et al.  Changes in circuIating B cells and immunoglobulin cIasses and subcIasses in a healthy aged popuIation , 1992, Clinical and experimental immunology.

[86]  J. Myśliwska,et al.  Level of NK cytotoxic activity in the elderly aged more than 80 years. , 1992, Archives of gerontology and geriatrics.

[87]  M. Irwin,et al.  Reduced natural killer cell cytotoxicity in depression but not in schizophrenia , 1991, Biological Psychiatry.

[88]  M R Rose,et al.  Evolution of senescence: late survival sacrificed for reproduction. , 1991, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[89]  T. Whiteside,et al.  Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity. , 1991, Natural immunity and cell growth regulation.

[90]  M. Cybulsky,et al.  Endothelial‐Dependent Mechanisms of Leukocyte Adhesion in Inflammation and Atherosclerosis a , 1990, Annals of the New York Academy of Sciences.

[91]  D. Knook,et al.  Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol , 1990, Mechanisms of Ageing and Development.

[92]  B. L. Beattie,et al.  Comparison of one- and two-dose regimens of influenza vaccine for elderly men. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[93]  R. Douglas,et al.  Immunization of elderly people with two doses of influenza vaccine , 1987, Journal of clinical microbiology.

[94]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[95]  B. Linn,et al.  CUMULATIVE ILLNESS RATING SCALE , 1968, Journal of the American Geriatrics Society.